Story · Medicine & Biotech
Paolo Tarantino Joins Miami Breast 2027 to Explore the Clinical Impact of New FDA Approvals in Breast Cancer
1 outlet · first reported by OncoDaily on
Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, shared on LinkedIn: “2026 has been a record year for FDA approvals in breast cancer! Miami Breast 2027 is an unparalleled (OncoDaily)
Coverage, in order
-
Paolo Tarantino Joins Miami Breast 2027 to Explore the Clinical Impact of New FDA Approvals in Breast CancerPaolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, shared on LinkedIn: “2026 has been a record year for FDA approvals in breast cancer! Miami Breast 2027 is an unparalleled
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.